Activities of the European Retinoblastoma Group (EURBG)
The biannual meeting of the International Society for Genetic Eye Diseases and Retinoblastoma (ISGEDR) will take place from September 11–13th, 2025, in Oslo. For more details, visit here. The organizers are pleased to announce that travel grants are now available for those wishing to attend the ISGEDR meeting.
As part of the 2025 ISGEDR bi-annual meeting, a dedicated session featuring scientific presentations by European Retinoblastoma experts will be held on Friday, September 12, 2025. European researchers interested in presenting are encouraged to submit their abstracts via the ISGEDR abstract submission platform, open until June 15, 2025.
The annual European Retinoblastoma Group (EURBG) business meeting will take place on September 13, 2025, in Oslo, alongside the ISGEDR meeting. Attendance is exclusive to EURBG members. Researchers and clinicians working on retinoblastoma in Europe are welcome to apply for free membership at www.eurbg.org.
About EURBG
The multidisciplinary European Retinoblastoma Group (EURBG) brings together experts from across Europe to:
· Discuss the latest findings from collaborative research
· Support international clinical case discussions
· Plan future joint projects to improve outcomes for children with retinoblastoma
EURBG remains committed to advancing research, fostering collaboration, and improving treatment for children with retinoblastoma across Europe. Through our continued efforts, we strive to expand knowledge, enhance care, and ensure the best possible outcomes for every child affected by this rare eye cancer.